Literature DB >> 17491702

Differential postprandial lipoprotein responses in type 2 diabetic men with and without clinical evidence of a former myocardial infarction.

Marius Carstensen1, Claus Thomsen, Ole Gotzsche, Jens Juul Holst, Jürgen Schrezenmeir, Kjeld Hermansen.   

Abstract

Postprandial lipemia plays an important role in the development of coronary heart disease through an elevation of triglyceride-rich lipoproteins. In type 2 diabetic male subjects, our aim was to compare postprandial lipemia in a high-risk population with former myocardial infarction (MI) with that of a lower risk population free of clinically detectable heart disease. 32 male type 2 diabetic subjects were included in the study. We matched 17 cases with a verified history of MI with 15 controls according to age, BMI, HbA1c, diabetes duration, smoking, and treatment of diabetes. Ongoing metformin, insulin, or lipid lowering pharmacological treatment were exclusion criteria. After a maximal exercise tolerance test and echocardiography, the subjects underwent a hyperinsulinemic, euglycemic clamp and a vitamin A fat loading test. Plasma triglyceride levels in the case group were significantly higher after 360 minutes (4.6 +/- 3.1 vs. 2.8 +/- 1.8 mmol/l, p = 0.04) and 480 minutes (3.6 +/- 2.2 vs. 2.4 +/- 2.4 mmol/l, p = 0.03), as was the incremental Area Under the Curve (iAUC) for the whole period (560 +/- 452 vs. 297 +/- 214 mmol x 480 min./l; p = 0.048). In addition, the retinyl palmitate responses in the chylomicron-fraction from the case group were significantly higher (iAUC 311,502 +/- 194,933 vs. 187,004 +/- 102,928 ng x 480 min./ml; p = 0.035). Type 2 diabetic males with prior MI had higher postprandial triglyceride-rich lipoprotein responses than those without MI, indicating that high responses may be a marker for a high-risk population.

Entities:  

Year:  2005        PMID: 17491702      PMCID: PMC1783690          DOI: 10.1900/RDS.2004.1.175

Source DB:  PubMed          Journal:  Rev Diabet Stud        ISSN: 1613-6071


  53 in total

1.  Postprandial lipaemia.

Authors:  J R Patsch
Journal:  Baillieres Clin Endocrinol Metab       Date:  1987-08

2.  Cross-sectional echocardiography in acute myocardial infarction: detection and localization of regional left ventricular asynergy.

Authors:  J J Heger; A E Weyman; L S Wann; J C Dillon; H Feigenbaum
Journal:  Circulation       Date:  1979-09       Impact factor: 29.690

Review 3.  Diabetes mellitus. Report of a WHO Study Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1985

4.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

5.  Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease.

Authors:  N Mero; R Malmström; G Steiner; M R Taskinen; M Syvänne
Journal:  Atherosclerosis       Date:  2000-05       Impact factor: 5.162

Review 6.  Dyslipidemia in patients with type 2 diabetes. relationships between lipids, kidney disease and cardiovascular disease.

Authors:  Wendy P Battisti; Joanne Palmisano; William E Keane
Journal:  Clin Chem Lab Med       Date:  2003-09       Impact factor: 3.694

7.  Enzyme immunoassay for intact human insulin in serum or plasma.

Authors:  L Andersen; B Dinesen; P N Jørgensen; F Poulsen; M E Røder
Journal:  Clin Chem       Date:  1993-04       Impact factor: 8.327

8.  Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man.

Authors:  A Hvidberg; M T Nielsen; J Hilsted; C Orskov; J J Holst
Journal:  Metabolism       Date:  1994-01       Impact factor: 8.694

9.  Apolipoprotein B-48 or its apolipoprotein B-100 equivalent mediates the binding of triglyceride-rich lipoproteins to their unique human monocyte-macrophage receptor.

Authors:  S H Gianturco; M P Ramprasad; R Song; R Li; M L Brown; W A Bradley
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-06       Impact factor: 8.311

10.  Heated dorsal hand vein sampling for metabolic studies: a reappraisal.

Authors:  K C Copeland; F A Kenney; K S Nair
Journal:  Am J Physiol       Date:  1992-11
View more
  13 in total

1.  Postprandial lipoproteins and cardiovascular disease risk in diabetes mellitus.

Authors:  Byambaa Enkhmaa; Zeynep Ozturk; Erdembileg Anuurad; Lars Berglund
Journal:  Curr Diab Rep       Date:  2010-02       Impact factor: 4.810

2.  Measures of postprandial lipoproteins are not associated with coronary artery disease in patients with type 2 diabetes mellitus.

Authors:  Gissette Reyes-Soffer; Steve Holleran; Wahida Karmally; Colleen I Ngai; Niem-Tzu Chen; Margarita Torres; Rajasekhar Ramakrishnan; William S Blaner; Lars Berglund; Henry N Ginsberg; Catherine Tuck
Journal:  J Lipid Res       Date:  2009-05-08       Impact factor: 5.922

3.  Serum lipid management in patients with type 1 and type 2 diabetes: a hospital-based cohort study.

Authors:  Yukiko Hasegawa; Tomoko Nakagami; Junko Oya; Chisato Isago; Moritoshi Kurita; Yuki Tanaka; Arata Ito; Reika Tsuzura; Naoki Hirota; Junnosuke Miura; Yasuko Uchigata
Journal:  Diabetol Int       Date:  2018-07-28

4.  Hepatocyte Small Heterodimer Partner Mediates Sex-Specific Effects on Triglyceride Metabolism via Androgen Receptor in Male Mice.

Authors:  Brian T Palmisano; Lin Zhu; Bridget Litts; Andreanna Burman; Sophia Yu; Joshua C Neuman; Uche Anozie; Thao N Luu; Emery M Edington; John M Stafford
Journal:  Metabolites       Date:  2021-05-20

5.  Effect of combination therapy with fenofibrate and simvastatin on postprandial lipemia in the ACCORD lipid trial.

Authors:  Gissette Reyes-Soffer; Colleen I Ngai; Laura Lovato; Wahida Karmally; Rajasekhar Ramakrishnan; Stephen Holleran; Henry N Ginsberg
Journal:  Diabetes Care       Date:  2012-10-01       Impact factor: 19.112

Review 6.  Combining insulins with oral antidiabetic agents: effect on hyperglycemic control, markers of cardiovascular risk and disease.

Authors:  Kjeld Hermansen; Lene Sundahl Mortensen; Marie-Louise Hermansen
Journal:  Vasc Health Risk Manag       Date:  2008

7.  Study of postprandial lipaemia in type 2 diabetes mellitus: exenatide versus liraglutide.

Authors:  Maria Voukali; Irene Kastrinelli; Sapfo Stragalinou; Dimitra Tasiopoulou; Pinelopi Paraskevopoulou; Nicholas Katsilambros; Alexandros Kokkinos; Nicholas Tentolouris; Ioannis Ioannidis
Journal:  J Diabetes Res       Date:  2014-08-04       Impact factor: 4.011

8.  Comparison of the effect of different intensity exercise on a bicycle ergometer on postprandial lipidemia in type II diabetic patients.

Authors:  Narges Argani; Gholamreza Sharifi; Jafar Golshahi
Journal:  ARYA Atheroscler       Date:  2014-05

Review 9.  Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and Pharmacodynamics.

Authors:  Lisbeth V Jacobsen; Anne Flint; Anette K Olsen; Steen H Ingwersen
Journal:  Clin Pharmacokinet       Date:  2016-06       Impact factor: 6.447

10.  Pre-Meal Effect of Whey Proteins on Metabolic Parameters in Subjects with and without Type 2 Diabetes: A Randomized, Crossover Trial.

Authors:  Ann Bjørnshave; Jens Juul Holst; Kjeld Hermansen
Journal:  Nutrients       Date:  2018-01-25       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.